The Covid-19 pandemic boosted demand for quick diagnostic testing to unprecedented levels, bringing into focus the crucial role of pathology players in the healthcare ecosystem. What trends in healthcare and medicine are driving the regional growth potential of the pathology industry? We find out from Dr Christopher Ting, CEO of Pathology Asia Group, which runs a network of pathology labs across Southeast Asia, including Innoquest Pathology in Malaysia (formerly known as Gribbles Pathology).